Long-term cost analysis of treatment options for benign prostatic hyperplasia in Norway

By Johansen Truls E. Bjerklund   Istad Jan Anders  

Scandinavian Journal of Urology and Nephrology, Vol. 41, Iss. 2, 2007-01 ,pp. : 124-131

Informa Healthcare

Access to resources Recommend Favorite

Long-term evaluation of Transurethral Needle Ablation of the prostate (TUNA) for treatment of benign prostatic hyperplasia (BPH): clinical outcome after 5 years

By Zlotta A.   Schulman C.   Giannakopoulos X.   Machlum H.   Ostrem E.  

European Urology Supplements, Vol. 1, Iss. 1, 2002-01 ,pp. : 129-129

Elsevier

Access to resources Recommend Favorite

Long-term 6-year experience with finasteride in patients with benign prostatic hyperplasia

By Lowe F.C.   McConnell J.D.   Hudson P.B.   Romas N.A.   Boake R.   Lieber M.   Elhilali M.   Geller J.   Imperto-McGinely J.   Andriole G.L.   Bruskewitz R.C.   Walsh P.C.   Bartsch G.   Nacey J.N.   Shah S.   Pappas F.   Ko A.   Cook T.   Stoner E.   Waldstreicher J.   FINASTERIDE STUDY GROUP  

Urology, Vol. 61, Iss. 4, 2003-04 ,pp. : 791-796

Elsevier

Access to resources Recommend Favorite

Long-term efficacy and safety of terazosin in patients with benign prostatic hyperplasia

By Lepor H.  

Urology, Vol. 45, Iss. 3, 1995-03 ,pp. : 406-413

Elsevier

Access to resources Recommend Favorite

Long-term treatment with finasteride in men with symptomatic benign prostatic hyperplasia: 10-year follow-up

By Lam J.S.   Romas N.A.   Lowe F.C.  

Urology, Vol. 61, Iss. 2, 2003-02 ,pp. : 354-358

Elsevier

Access to resources Recommend Favorite